Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Gordon

Vascular & Interventional Radiology Lakeland, FL Medical Doctor

NPI 1023248648 CMS profile 478230

2115 Crystal Grove Dr, Lakeland, FL 33801

Open in the dashboard

General payments

$38,501

243 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Michael Gordon of Lakeland, FL is reported in the CMS Open Payments database as having received $38,501 across 243 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $10,870 39
2024 General $11,186 49
2023 General $9,348 65
2022 General $3,659 34
2021 General $1,203 32
2020 General $391 7
2019 General $1,844 17

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Gordon
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Michael Gordon were reported at $10,870. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Michael Gordon Vascular & Interventional Radiology median Middle half National median
2019 $1,844 $422 $125–$1,555 $163
2020 $391 $200 $68–$652 $114
2021 $1,203 $280 $99–$866 $132
2022 $3,659 $433 $137–$1,497 $149
2023 $9,348 $506 $152–$2,019 $160
2024 $11,186 $556 $175–$1,930 $164
2025 $10,870 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AngioDynamics, Inc. $26,871 8 payments
  2. Penumbra, Inc. $3,046 61 payments
  3. Cordis US Corp. $2,129 9 payments
  4. W. L. Gore & Associates, Inc. $1,844 30 payments
  5. Inari Medical, Inc. $1,036 37 payments
  6. Medtronic, Inc. $416 13 payments
  7. Boston Scientific Corporation $409 11 payments
  8. Bard Peripheral Vascular, Inc. $365 6 payments
  9. Maquet Cardiovascular U.S. Sales, L.L.C. $339 1 payment
  10. Imperative Care, INc $326 13 payments
  11. Other $1,722 54 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Long term medical supply or device loan $26,708 5 payments
  2. Food and Beverage $8,647 232 payments
  3. Travel and Lodging $2,855 5 payments
  4. Consulting Fee $290 1 payment
Products named General payments · program years 2019–2025
  1. Auryon Laser System 100-120 Vac Et $17,625 3 payments
  2. Auryon Laser System 100-120 Vac Cv $9,083 2 payments
  3. ANGIOGUARD $2,000 7 payments
  4. FLOWTRIEVER CATHETER, S $1,346 47 payments
  5. Indigo $1,198 4 payments
  6. Indigo System $1,006 27 payments
  7. CT THROMBECTOMY SYSTEM KIT $680 23 payments
  8. GORE VIABAHN VBX Balloon Expandable Endo $524 8 payments
  9. Penumbra System $494 15 payments
  10. EXCLUDER Conformable AAA Endoprosthesis with Active Control $349 6 payments
  11. Other $4,957 141 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 151 billing codes

Paid by Medicare

$84,418

Medicare's payments for the services billed

Medicare patients

311

Average age 73

Services billed

1,634

143 women, 168 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Chronic kidney disease 64%
Diabetes 56%
Ischemic heart disease 53%
Heart failure 50%
Arthritis 49%
Atrial fibrillation 38%
COPD 36%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

243 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record